Journal of Radioanalytical and Nuclear Chemistry

, Volume 302, Issue 1, pp 69–77

Optimization of fundamental parameters in routine production of 90Y-hydroxyapatite for radiosynovectomy

  • Mohammad R. Davarpanah
  • Hossein A. Khoshhosn
  • Mohsen Harati
  • S. Attar Nosrati
  • Masoumeh Zoghi
  • Mohammad Mazidi
  • M. Ghannadi Maragheh
Article

Abstract

Hydroxyapatite was applied as a carrier adsorbing 90Y3+ ions for 90Y-HA colloid production. The radiopharmaceutical colloid was prepared by adding an acidic solution of 90YCl3 to HA suspension in saline solution. Effective parameters on labeling of 90Y-HA were evaluated. Adsorption and cation-exchange properties were studied using inductively coupled plasma elemental analysis and N2 adsorption–desorption isotherm method. Radionuclidic purity was over 99.9 %. Labeling yield and radiochemical purity were >99 %. Radiochemical purity was evaluated also in human albumin for 7 days at 37 °C. Biodistribution studies have shown complete retention of injected radioactivity at the administration site up to 72 h.

Keywords

Radiosynovectomy Rheumatoid arthritis Yttrium-90 Hydroxyapatite Colloidal radiopharmaceuticals Cation exchange 

Supplementary material

10967_2014_3326_MOESM1_ESM.docx (532 kb)
Supplementary material 1 (DOCX 531 kb)

References

  1. 1.
    Camp AV (1972) Synovectomy of the knee in rheumatoid arthritis. I. Range of movement and quadriceps lag after surgery. Ann Rheum Dis 31(3):155–158. doi:10.1136/ard.31.3.155 CrossRefGoogle Scholar
  2. 2.
    O’Duffy EK, Clunie GPR, Lui D, Edwards JCW, Ell PJ (1999) Double blind glucocorticoid controlled trial of samarium-153 particulate hydroxyapatite radiation synovectomy for chronic knee synovitis. Ann Rheum Dis 58(9):554–558. doi:10.1136/ard.58.9.554 CrossRefGoogle Scholar
  3. 3.
    Schneider P, Farahati J, Reiners C (2005) Radiosynovectomy in rheumatology, orthopedics, and hemophilia. J Nucl Med 46(1 suppl):48S–54SGoogle Scholar
  4. 4.
    Couto RM, De Souza AA, Herrerias R, Muramoto E, Mengatti J, Barboza M, Araujo E (2010) Hydroxyapatite labelled with yttrium-90 or lutetium-177 for radiation synovectomy. Atoms for Peace: an International Journal 3(1):19–25. doi:10.1504/afp.2010.031017 CrossRefGoogle Scholar
  5. 5.
    Savio E, Ures M, Zeledon P, Trindade V, Paolino A, Mockford V, Malanga A, Fernandez M, Gaudiano J (2004) 188Re radiopharmaceuticals for radiosynovectomy: evaluation and comparison of tin colloid, hydroxyapatite and tin-ferric hydroxide macroaggregates. BMC Nucl Med 4(1):1–10CrossRefGoogle Scholar
  6. 6.
    Junfeng Y, Duanzhi Y, Xiaofeng M, Zili G, Jiong Z, Yongxian W, Knapp FF Jr (1999) [188Re]rhenium sulfide suspension: a potential radiopharmaceutical for tumor treatment following intra-tumor injection. Nucl Med Biol 26(5):573–579. doi:10.1016/S0969-8051(99)00017-7 CrossRefGoogle Scholar
  7. 7.
    Kothari K, Suresh S, Sarma HD, Meera V, Pillai MRA (2003) 188Re-labeled hydroxyapatite particles for radiation synovectomy. Appl Radiat Isot 58(4):463–468. doi:10.1016/S0969-8043(03)00028-9 CrossRefGoogle Scholar
  8. 8.
    Shukla J, Bandopadhyaya GP, Shamim SA, Kumar R (2007) Characterization of Re-188-Sn microparticles used for synovitis treatment. Int J Pharm 338(1–2):43–47. doi:10.1016/j.ijpharm.2007.01.014 CrossRefGoogle Scholar
  9. 9.
    Williams ED, Caughey DE, Hurley PJ, John MB (1976) Distribution of yttrium-90 ferric hydroxide colloid and gold-198 colloid after injection into knee. Ann Rheum Dis 35(6):516–520. doi:10.1136/ard.35.6.516 CrossRefGoogle Scholar
  10. 10.
    Bayly RJ, Peacegood JA, Peake SC (1973) 90Y ferric hydroxide colloid. Ann Rheum Dis 32(Supplement):10. doi:10.1136/ard.32.Suppl.10 CrossRefGoogle Scholar
  11. 11.
    Gumpel JM, Farran HE, Williams ED (1974) Use of yttrium-90 in persistent synovitis of the knee. II. Direct comparison of yttrium colloid resin and yttrium citrate. Ann Rheum Dis 33(2):126–128. doi:10.1136/ard.33.2.126 CrossRefGoogle Scholar
  12. 12.
    Gedik G, Uğur Ö, Atilla B, Pekmezci M, Yildirim M, Seven B, VaroĞlu E (2006) Comparison of extraarticular leakage values of radiopharmaceuticals used for radionuclide synovectomy. Ann Nucl Med 20(3):183–188. doi:10.1007/bf03027428 CrossRefGoogle Scholar
  13. 13.
    Gumpel JM, Hasp R, Loewi G (1973) Comparison of 90Y ferric hydroxide colloid with the citrate and resin colloids: a preliminary animal study. Ann Rheum Dis 32(Supplement):11. doi:10.1136/ard.32.Suppl.11 CrossRefGoogle Scholar
  14. 14.
    Khalid M, Mushtaq A (2005) Preparation and in vitro stability of (n, γ) yttrium-90 hydroxyapatite. Appl Radiat Isot 62(4):587–590. doi:10.1016/j.apradiso.2004.08.046 CrossRefGoogle Scholar
  15. 15.
    Pandey U, Mukherjee A, Chaudhary PR, Pillai MRA, Venkatesh M (2001) Preparation and studies with 90Y-labelled particles for use in radiation synovectomy. Appl Radiat Isot 55(4):471–475. doi:10.1016/S0969-8043(01)00061-6 CrossRefGoogle Scholar
  16. 16.
    Kothari K, Pillai MRA, Unni PR, Shimpi HH, Noronha OPD, Samuel AM (1999) Preparation, stability studies and pharmacological behavior of [186Re]Re-HEDP. Appl Radiat Isot 51(1):51–58. doi:10.1016/S0969-8043(98)00195-X CrossRefGoogle Scholar
  17. 17.
    Chinol M, Vallabhajosula S, Goldsmith SJ, Klein MJ, Deutsch KF, Chinen LK, Brodack JW, Deutsch EA, Watson BA, Tofe AJ (1993) Chemistry and biological behavior of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy. J Nucl Med 34(9):1536–1542Google Scholar
  18. 18.
    Kahan A, Mödder G, Menkes CJ, Verrier P, Devaux JY, Bonmartin A, De Rycke Y, Manil L, Chossat F, Tebib J (2004) 169Erbium-citrate synoviorthesis after failure of local corticosteroid injections to treat rheumatoid arthritis-affected finger joints. Clin Exp Rheumatol 22(6):722–726Google Scholar
  19. 19.
    Mortazavi SMJ, Asadollahi S, Farzan M, Shahriaran S, Aghili M, Izadyar S, Lak M (2007) 32P colloid radiosynovectomy in treatment of chronic haemophilic synovitis: iran experience. Haemoph 13(2):182–188. doi:10.1111/j.1365-2516.2006.01424.x CrossRefGoogle Scholar
  20. 20.
    Chakraborty S, Das T, Banerjee S, Sarma HD, Venkatesh M (2006) Preparation and preliminary biological evaluation of 177Lu-labelled hydroxyapatite as a promising agent for radiation synovectomy of small joints. Nucl Med Commun 27(8):661–668CrossRefGoogle Scholar
  21. 21.
    Yttrium [90Y] colloid CIS bio international, colloid suspension for local injection (2008) Summary of product characteristics. CIS bio international Member of IBA groupGoogle Scholar
  22. 22.
    Reily RM (2010) Monoclonal antibody and peptide-targeted radiotherapy of cancer. Wiley, HobokenCrossRefGoogle Scholar
  23. 23.
    Unni PR, Chaudhari PR, Venkatesh M, Ramamoorthy N, Pillai MRA (2002) Preparation and bioevaluation of 166Ho labelled hydroxyapatite (HA) particles for radiosynovectomy. Nucl Med Biol 29(2):199–209. doi:10.1016/S0969-8051(01)00303-1 CrossRefGoogle Scholar
  24. 24.
    Pandey U, Bapat K, Sarma H, Dhami P, Naik PW, Samuel G, Venkatesh M (2009) Bioevaluation of 90Y-labeled particles in animal model of arthritis. Ann Nucl Med 23(4):333–339. doi:10.1007/s12149-009-0239-3 CrossRefGoogle Scholar
  25. 25.
    Chattopadhyay S, Vimalnath KV, Saha S, Korde A, Sarma HD, Pal S, Das MK (2008) Preparation and evaluation of a new radiopharmaceutical for radiosynovectomy, 111Ag-labelled hydroxyapatite (HA) particles. Appl Radiat Isot 66(3):334–339. doi:10.1016/j.apradiso.2007.09.003 CrossRefGoogle Scholar
  26. 26.
    Unni PR, Pillai MRA 166Ho labelled hydroxy apatite particles for radiosynovectomy. In: Therapeutic applications of radiopharmaceuticals, Hyderabad, India, 18–22 January 1999. IAEA-TECDOC-1228, pp 249–256Google Scholar
  27. 27.
    Kumar PG, Anand SS, Singh J, Chawla ML (2005) Radiosynoviorthesis in the treatment of disabling arthritis. Med J Armed Forces India 61(4):367–368. doi:10.1016/S0377-1237(05)80070-X CrossRefGoogle Scholar
  28. 28.
    Janković D, Maksin T, Djokić D, Milonjić S, Nikolić N, Mirković M, VranjeŠ-Djurić S (2008) Particle size analysis: 90Y and 99mTc-labelled colloids. J Microsc 232(3):601–604. doi:10.1111/j.1365-2818.2008.02124.x CrossRefGoogle Scholar
  29. 29.
    Jurisson S, Berning D, Jia W, Ma D (1993) Coordination compounds in nuclear medicine. Chem Rev 93(3):1137–1156. doi:10.1021/cr00019a013 CrossRefGoogle Scholar
  30. 30.
    Aghayan H, Mahjoub AR, Khanchi AR (2013) Samarium and dysprosium removal using 11-molybdo-vanadophosphoric acid supported on Zr modified mesoporous silica SBA-15. Chem Eng J 225:509–519. doi:10.1016/j.cej.2013.03.092 CrossRefGoogle Scholar

Copyright information

© Akadémiai Kiadó, Budapest, Hungary 2014

Authors and Affiliations

  • Mohammad R. Davarpanah
    • 1
  • Hossein A. Khoshhosn
    • 1
  • Mohsen Harati
    • 1
  • S. Attar Nosrati
    • 1
  • Masoumeh Zoghi
    • 1
  • Mohammad Mazidi
    • 1
  • M. Ghannadi Maragheh
    • 1
  1. 1.Nuclear Science and Technology Research Institute (NSTRI)TehranIran

Personalised recommendations